The new collaboration furthers the companies’ ongoing relationship concerning use of Bruker’s state-of-the-art MALDI-TOF instruments with VeriStrat and other clinical diagnostics in development.
Read MoreA summary of two studies presented at AACR 2013 in Washington, DC.
Read More
The NCI will support Insight Genetics by providing services of two CLIA-certified labs that will further validate the assay, access to clinical samples, subject matter expertise, and statistical consultation.
Read More
Industry experts discuss obstacles and successes.
Read More
The company aims to further enhance confidence in a patient’s diagnosis, especially in cases of discriminating lung SqCC versus ADC, where a correct diagnosis is critical for therapeutic direction.
Read More